BRIEF published on 08/15/2024 at 13:05, 3 months 6 days ago CureVac nomme le Dr Mehdi Shahidi, oncologue et expert en développement de médicaments, au conseil de surveillance Conseil De Surveillance Oncologie CureVac Technologie De L'ARNm Dr Mehdi Shahidi
PRESS RELEASE published on 08/15/2024 at 13:03, 3 months 6 days ago CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma CureVac initiates Part B of Phase 1 study for cancer vaccine CVGBM in resected glioblastoma patients, focusing on safety and immunogenicity CureVac MRNA Glioblastoma CVGBM Phase 1 Study
PRESS RELEASE published on 08/15/2024 at 13:00, 3 months 6 days ago CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board CureVac appoints Dr. Mehdi Shahidi, an expert in oncology and drug development, as independent director to its Supervisory Board, enhancing focus on mRNA-based cancer vaccines Oncology Drug Development CureVac MRNA Dr. Mehdi Shahidi
BRIEF published on 07/11/2024 at 13:05, 4 months 10 days ago CureVac Updates Trial Dates for Patent Litigation Against Pfizer/BioNTech CureVac Patent Litigation Legal Update Pfizer/BioNTech Trial Dates
BRIEF published on 07/11/2024 at 13:05, 4 months 10 days ago CureVac met à jour les dates des procès pour les litiges en matière de brevets contre Pfizer/BioNTech CureVac Contentieux Des Brevets Pfizer/BioNTech Dates Du Procès Mise À Jour Juridique
PRESS RELEASE published on 07/11/2024 at 13:00, 4 months 10 days ago CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech CureVac provides trial date updates for patent litigation against Pfizer/BioNTech in multiple geographies, including the U.S., UK, and Germany BioNTech CureVac Patent Litigation Pfizer Trial Dates
BRIEF published on 07/03/2024 at 08:17, 4 months 18 days ago CureVac Announces Strategic Restructuring to Focus on High-Value mRNA Opportunities Licensing Agreement MRNA Technology Oncology Research Strategic Restructuring Workforce Reduction
BRIEF published on 07/03/2024 at 08:17, 4 months 18 days ago CureVac annonce une restructuration stratégique pour se concentrer sur les opportunités d'ARNm de grande valeur Recherche En Oncologie Technologie ARNm Restructuration Stratégique Réduction Des Effectifs Contrat De Licence
BRIEF published on 07/03/2024 at 08:14, 4 months 18 days ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement Licensing Agreement GSK CureVac MRNA Vaccines
BRIEF published on 07/03/2024 at 08:14, 4 months 18 days ago GSK et CureVac vont restructurer leur collaboration dans le cadre d'un nouvel accord de licence GSK CureVac Vaccins Contrat De Licence ARNm
Published on 11/21/2024 at 20:15, 47 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 52 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 1 hour 2 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 1 hour 37 minutes ago Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 3 hours 27 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 19:01, 2 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 2 hours 26 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 3 hours 4 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 3 hours 10 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 3 hours 10 minutes ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 06:58, 14 hours 4 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 4 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 4 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 1 hour ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
